Published in Liver on June 01, 2002
Hepatitis C, porphyria cutanea tarda and liver iron: an update. Liver Int (2012) 2.10
The effect of iron depletion on chronic hepatitis C virus infection. Hepatol Int (2008) 0.96
HFE gene in primary and secondary hepatic iron overload. World J Gastroenterol (2007) 0.81
Iron as a cofactor in chronic hepatitis C infection. Liver (2002) 0.78
Asunaprevir, a protease inhibitor for the treatment of hepatitis C infection. Ther Clin Risk Manag (2014) 0.77
Effect of hepatic iron concentration and viral factors in chronic hepatitis C-infected patients with thalassemia major, treated with interferon and ribavirin. Int J Gen Med (2011) 0.76
Immune responsiveness to Mycobacterium leprae and other mycobacterial antigens throughout the clinical and histopathological spectrum of leprosy. Clin Exp Immunol (1973) 4.12
Characterization of the cellular immune defect in lepromatous leprosy: a specific lack of circulating Mycobacterium leprae-reactive lymphocytes. Clin Exp Immunol (1971) 3.69
Application of the passive haemolysis test for the determination of rubella virus antibodies. Acta Pathol Microbiol Scand B (1975) 2.66
Epidemiology and clinical features of imported dengue fever in Europe: sentinel surveillance data from TropNetEurop. Clin Infect Dis (2002) 2.02
[Genetic diagnostic test for hemochromatosis]. Tidsskr Nor Laegeforen (1998) 2.02
Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein. Digestion (1997) 1.92
Epidemiology and clinical features of vivax malaria imported to Europe: sentinel surveillance data from TropNetEurop. Malar J (2004) 1.90
Thyroid dysfunction during treatment of chronic hepatitis C with interferon alpha: no association with either interferon dosage or efficacy of therapy. J Intern Med (2002) 1.80
Pelvic inflammatory disease associated with Chlamydia trachomatis infection after therapeutic abortion. A prospective study. Br J Vener Dis (1983) 1.69
Hepatitis C in the general adult population of Oslo: prevalence and clinical spectrum. Scand J Gastroenterol (2003) 1.63
False-negative results of a ligase chain reaction assay to detect Chlamydia trachomatis due to inhibitors in urine. Eur J Clin Microbiol Infect Dis (1997) 1.61
Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol (1998) 1.57
Association between serum 25(OH)D and death from prostate cancer. Br J Cancer (2009) 1.55
Use of NS-4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5 and 6. J Gen Virol (1995) 1.55
Therapeutic abortion and Chlamydia trachomatis infection. Br J Vener Dis (1982) 1.53
Evidence that the mechanism of immunological tolerance ("central failure") is operative in the lack of host resistance in lepromatous leprosy. Scand J Immunol (1972) 1.50
Mechanism of "reactions" in borderline tuberculoid (BT) leprosy. A preliminary report. Acta Pathol Microbiol Scand Suppl (1973) 1.48
HFE gene mutation (C282Y) and phenotypic expression among a hospitalised population in a high prevalence area of haemochromatosis. Gut (2000) 1.47
Second-generation anti-HCV tests predict infectivity. Vox Sang (1992) 1.43
Neuropathological findings after intracerebral implantation of microdialysis catheters. Neuroreport (1998) 1.41
Reinventing long-term care. Minn Med (2001) 1.39
Immunoglobulin class specific antibodies to M. leprae in leprosy patients, including the indeterminate group and healthy contacts as a step in the development of methods for sero-diagnosis of leprosy. Clin Exp Immunol (1982) 1.38
Joining the ranks of the employed. Minn Med (1996) 1.37
Transfer of penicillin G and ampicillin into human skin blisters induced by suction. Scand J Infect Dis Suppl (1978) 1.36
Treatment of chronic hepatitis C in injecting drug users: 5 years' follow-up. Eur Addict Res (2002) 1.35
Diagnosis of recent Herpes simplex infections. A modified immunofluorescent test for the detection of specific Herpes simplex IgM antibodies after staphylococcal adsorption of IgG. Acta Pathol Microbiol Scand B Microbiol Immunol (1974) 1.33
Neutrophil granulocyte function in bacterial infections. Lancet (1972) 1.32
High levels of messenger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastases. Clin Cancer Res (1997) 1.30
Age as a risk factor for severe manifestations and fatal outcome of falciparum malaria in European patients: observations from TropNetEurop and SIMPID Surveillance Data. Clin Infect Dis (2003) 1.29
The diagnostic value of determination of IgM antibodies against Mycoplasma pneumoniae by the indirect immunofluorescent antibody test. Acta Pathol Microbiol Scand B (1976) 1.29
Imported schistosomiasis in Europe: sentinel surveillance data from TropNetEurop. J Travel Med (2003) 1.27
Expression of a novel factor, com1, is regulated by 1,25-dihydroxyvitamin D3 in breast cancer cells. Cancer Res (2000) 1.27
Serum ferritin and transferrin saturation in patients with chronic alcoholic and non-alcoholic liver diseases. J Intern Med (1994) 1.25
Human leucocyte migration: studies with an improved skin chamber technique. Acta Pathol Microbiol Scand C (1977) 1.25
Antimycobacterial antibodies in sera from patients throughout the clinico-pathological disease spectrum of leprosy. Acta Pathol Microbiol Scand B Microbiol Immunol (1974) 1.23
Identification of high levels of protein phosphatase-1 in rat liver nuclei. FEBS Lett (1986) 1.22
Proliferative human T cell responses to Chlamydia trachomatis in vitro. Acta Pathol Microbiol Immunol Scand C (1983) 1.19
Sensitivity of western blotting (compared with ELISA and immunofluorescence) during seroconversion after HTLV-III infection. Lancet (1986) 1.17
Pharmacokinetics and tissue penetration of ceftazidime: studies on lymph, aqueous humour, skin blister, cerebrospinal and pleural fluid. J Antimicrob Chemother (1983) 1.15
Behavior of Mycobacterium leprae in human macrophages in vitro. Infect Immun (1973) 1.15
Vectorcardiographic evolution of left ventricular hypertrophy. Br Heart J (1968) 1.14
Association between HLA-BW40 and alcoholic liver disease with cirrhosis. Br Med J (1978) 1.13
Kinetics of thiamin and thiamin phosphate esters in human blood, plasma and urine after 50 mg intravenously or orally. Eur J Clin Pharmacol (1993) 1.11
Fecal calprotectin concentration in patients with colorectal carcinoma. Dis Colon Rectum (1998) 1.09
European cluster of imported falciparum malaria from Gambia. Euro Surveill (2008) 1.09
HIV dementia and apolipoprotein E. Acta Neurol Scand (1997) 1.07
Regulation of development in the fully grown mouse oocyte: chromosome-mediated temporal and spatial differentiation of the cytoplasm and plasma membrane. J Embryol Exp Morphol (1986) 1.06
Comparison of the sensitivity of four rapid assays for the detection of antibodies to HIV-1/HIV-2 during seroconversion. Clin Diagn Virol (1996) 1.05
Low-grade intestinal lymphoma of intraepithelial T lymphocytes with concomitant enteropathy-associated T cell lymphoma: case report suggesting a possible histogenetic relationship. Hum Pathol (1989) 1.04
Hepatitis B antibodies in HIV-infected homosexual men are associated with more rapid progression to AIDS. AIDS (1992) 1.04
Protection of phagocytosed bacteria against antimicrobial agents. Scand J Infect Dis Suppl (1978) 1.03
Chlamydial serum IgG antibodies in patients with acute salpingitis measured by an enzyme-linked immunosorbent assay. Acta Pathol Microbiol Immunol Scand C (1982) 1.03
Strategies for assessing the implications of malformed frogs for environmental health. Environ Health Perspect (2000) 1.03
Influence of serum on the bactericidal activity of neutrophil granulocytes. Acta Pathol Microbiol Scand B Microbiol Immunol (1973) 1.02
Effect of combined interferon-alpha induction therapy and ribavirin on chronic hepatitis C virus infection: a randomized multicentre study. Scand J Gastroenterol (2002) 1.02
Utilization of endoscopic inoculation in a mouse model of intrauterine infection-induced preterm birth: role of interleukin 1beta. Biol Reprod (1999) 1.01
Long-term prognosis of patients with alcoholic liver cirrhosis: a 15-year follow-up study of 100 Norwegian patients admitted to one unit. Scand J Gastroenterol (2004) 1.00
In vitro perfusion studies on human umbilical arteries. I. Vasoactive effects of serotonin, PGF2 alpha and PGE2. Acta Obstet Gynecol Scand (1986) 0.99
Concomitant determination of thiamin and its phosphate esters in human blood and serum by high-performance liquid chromatography. J Chromatogr (1991) 0.99
Oxygen uptake/heart rate relationship in leg and arm exercise, sitting and standing. J Appl Physiol (1975) 0.98
Long-term outcome of chronic hepatitis C virus infection in primary hypogammaglobulinaemia. QJM (1999) 0.97
An indirect immunofluorescent antibody test for determination of Rubella virus specific IgM antibodies. Elimination of secondary IgM rheumatoid factor staining after absorption of serum IgG with Staphylococcal protein A. Acta Pathol Microbiol Scand C (1978) 0.97
A rubella epidemic in an unvaccinated pregnant population. I. Screening methods and serological results. Scand J Infect Dis (1981) 0.97
Blood and serum thiamin and thiamin phosphate esters concentrations in patients with alcohol dependence syndrome before and after thiamin treatment. Alcohol Clin Exp Res (1992) 0.96
Report on the Mycological Diagnostic Laboratory, the Queen's University of Belfast, 1960. Ulster Med J (1961) 0.96
A rotavirus staphylococcal co-agglutination test. Acta Pathol Microbiol Immunol Scand B (1983) 0.96
Relevance of a combined HIV antigen/antibody assay to detect early HIV infections in a low prevalence population: case reports. Clin Lab (2004) 0.96
Variation of hepatitis C virus hypervariable region 1 in immunocompromised patients. J Infect Dis (1997) 0.95
Penetration of antibiotics into human leukocytes and dermal suction blisters. Rev Infect Dis (1983) 0.95
An outbreak of hepatitis A among homosexuals linked to a family outbreak. Epidemiol Infect (2002) 0.93
Screening urine samples by leukocyte esterase test and ligase chain reaction for chlamydial infections among asymptomatic men. J Clin Microbiol (1995) 0.93
Comparison of genetic risk in three candidate genes (TCF7L2, PPARG, KCNJ11) with traditional risk factors for type 2 diabetes in a population-based study--the HUNT study. Scand J Clin Lab Invest (2009) 0.93
Mesalazine suppositories versus hydrocortisone foam in patients with distal ulcerative colitis. A comparison of the efficacy and practicality of two topical treatment regimens. Scand J Gastroenterol (1995) 0.93
Low frequency of complications in imported falciparum malaria: a review of 222 cases in south-eastern Norway. Scand J Infect Dis (1999) 0.92
Very high expression of an anti-carcinoembryonic antigen single chain Fv antibody fragment in the yeast Pichia pastoris. J Biotechnol (2000) 0.91
Standardization of the nitroblue tetrazolium test. Influence of pH, dye concentration and sample storage. Scand J Infect Dis (1977) 0.90
Serum carbohydrate-deficient transferrin as a marker of alcohol consumption in patients with chronic liver diseases. Alcohol Clin Exp Res (1993) 0.90
Heritable thrombophilia and hypofibrinolysis. Possible causes of retinal vein occlusion. Arch Ophthalmol (1999) 0.90
High prevalence of the hemochromatosis-associated Cys282Tyr HFE gene mutation in a healthy Norwegian population in the city of Oslo, and its phenotypic expression. Scand J Gastroenterol (1999) 0.89
Protein C in patients with alcoholic cirrhosis and other liver diseases. J Hepatol (1992) 0.89
Genotype, viral load and age as independent predictors of treatment outcome of interferon-alpha 2a treatment in patients with chronic hepatitis C. Construct group. Scand J Infect Dis (1997) 0.89
Outcome following liver transplantation for primary sclerosing cholangitis in the Nordic countries. Scand J Gastroenterol (2003) 0.89
Low levels of serum calcidiol in an African population compared to a North European population. Eur J Endocrinol (1999) 0.89